>PROKKA_00001 Clostridium P-47 protein
MNNLKPFIYYDWKKTILKNAKESYSINEIIPKTFFMELHGTKITNSTLNGTWKAWNLTDE
GEGSHPVLKCIIDDGYLDMNFGASSEKIPLKNVWIKLCMKINPNSDGTYSIPEKSSSFYI
KDNSLKISKDNLILDKYLNKLMLSYFKNNIKNIEMFINKSRIQTKVVGDLSLLGWNTENS
VSFRTMNEFIKKDNLYPKDFKAVYSYRKMTFTATGTFDSWEMTTGADGRNIRFKCPIKSA
AYDLDGDVFNSSTENFLLIQVDLTYFDSKTTINDPTGENDGKQFNLKVKTNDDKLKNVLI
VTYNLTDTDGSMSSEDKDFLSLAFRNWFNDNIQQFEQIFAYILLDETAKIPEYQWLKPTQ
ISYGSASVETANDEPDLDASIFSAMSMVENNTNSTPSHAVDNRMLQLTKTQAAFGISFPL
FIEHFLKQALLSSQFISVDDIVADINTLTITNNKQIIFGKVENSDGKNVDSSLKPGKLKL
SLQNNLIVLELFDLTWEQGRGVTGHFDFRQEYELTLESKSEKQIPILKVHDEPEIEYYVE
EAQWKANEDMIVSAVVGTVFSMILGAGMKLAGSALSKAGKLIRSKATTIKGRKKIYINRS
NVRQLRKDSGVTEMELQRINRRNSSIASEDARFISNNGTTSIQTLGDMKKKPMSTGQRIA
IGVKKITGTAVMFGAVGLGMNFGEMLINYINAMENNDYSAIPGINSFMQQCIGAMQWPDK
DSELKVTFGKLQGIYLLGGTLEKNNKPNSK*
>PROKKA_00002 hypothetical protein
MNQTFSFNFDDTLSNSSGLINLEKINQNCSPNYQYFKIKFIGGYLHIKNKYGDILEKYDL
KDLISLIALKKDYLKLSSPNNKKPNEFTNIKNKHLENRFNLYVINEDINGKITKNGILEE
IILNRLLLSILLGNEENLLQIA*
>PROKKA_00003 RNA polymerase factor sigma-70
MKNLFFLMNTLKDDNKKFEDIYMNYKDLIDIFIKKYNLSENYNDILKHFWIILIKADLNK
FNTENDLNKYISKCLKRYCLSICMKKNRDKKIIYNSEITDINLNLIQDSCFNDIEFEFKD
LISILPNTQQNIIYMKFFKDMKDIDIAKKLKISRQSVYKNKNLALEKLKPILKELINI*
>PROKKA_00004 Clostridium P-47 protein
MNTYGWDIVYGCSKRVVNKHLKEYITKNNIQFLYSNIDKKQEIKMVFDNWEIINGGSSNF
LRIKTPIKEGYFKVRNTTVDLSGINPVLEIKLDFFNDISNPNIKELKFNFGSESNDDIKI
IVSDLNGNLQEEDEFYFNKLLINAFIQNEKQISYIFASLNVTSDIEWMNPKQFKFVYYSP
TDNSDGYLFILSVVTNRDISKLSANVDGNILGNNSEVGLLISEKLFLQNMVLSRLSSNMG
SNINKNNFEVISTSDTTGRIVNNSTLNWYGLKVAALYYYPKINNFSMQLFEGNKLKISLR
GLVRLTGLEAVYSDFEIQSINKFVYNSTNKKAYFEVDKNPTSSYKYHLFPGDLISLAVLS
SVTHWSIKSIEGALGFELINNFVDLINNTIKWNNLKISQVTNVTLNVGFCIQGNAN*
>PROKKA_00005 Botulinum neurotoxin type E precursor
MKINNNFNIDSLIDNRDVAIVRGRKTDTFFKVFQVAPNIWIAPERYYGESLNINEDQKSD
GGIYDSNFLSTNDEKDEFLQATVKILQRINNNVIGAKLLSLISTAIPFPYEYKPGDYRQT
NYLVSKDNQHYYTANLVIFGPGTNIVENNAIYYKKEDSENGMGTMSEIWFQPFLTYKYGQ
FYVDPALELIKCLIKSLYYLYGIKPSDDLSIPYRLRSELNSFEYSELDMIDFLISGGTEY
KLLDTNPYWFTDNYFIDAPKNFEKYKNDYETKIKNNNDIANSIKLYLEQKFKTNAQDIWE
LNLSYFSTEFEIMMPEIFNNALNHYYRKEYYVIDYFKNYNINGFINGQIKTILPLSKYNK
NIINKPELVVNLINENNTVLMKSNVYGDGLKGTMDNFYAAYKIPYNIGDEYHINYSYLNN
VNVEEINNIPPINDADIYPYRKNSDPFIPVYNITETKEINTTTPLSVNYLQAQVTNSNDI
SLSSDFSKVISSKDRSLVYSFLDNTIDYLDSIKYDEPIDTDKKYYLWLKEIFRNYSFDMT
ETQEVNTPCGINKVVPWLGKALNILNTGNSFIEEFKSLGPISLINKKENITMPKIEIDEI
PNSMLNLSFKDLSENLFNRFSKNNSYFEKIYYDFLDQWWTQYYSQYFDLICMAKKSILAQ
ETLIKKIIQKKLSYLIGNSNISSDNLALMNLTTTNTLRDISNESQIAMNNVDSFLNSAAI
CVFEGNIYSKFISFMEQCINNINKNTREFIQKCTNITENEKLQLINQNIFSSLDFDFLNI
ENLKSLFSSETALLIKEETSPYELVLYAFQEPDNNAIGDASAKNTSIEYSKDIDLVYGIN
SDALYLNGSNQSISFSNDFFENGLTNSFSIYFWLRNLGKDTIKSKLIGSKEDNCGWEIYF
QDTGLVFNMIDSNGNEKNIYLSDVSNNSWHYITISVDRLKEQLLIFIDDNLVANESIKEI
LNIYSSNIISLLSENNPSYIEGLTILNKPTTSQEVLNNYFKVLNNSYIRDSNEERLEYNK
TYQLYNYVFSDKPICEVKQNNNIYLTINNTNNLNLQPSKFKLLSINSNKQYVQKFDEVII
SILGNMEKYIDISEDNRLQLIDNKNGAKKMIISNDMFISNCLTLSCGGKYICLSMKDENH
NWMICNNDMSKYLYLWSFK*
>PROKKA_00006 Botulinum neurotoxin type A precursor
MPFVNKQFNYKDPVNGVDIAYIKIPNAGQMQPVKAFKIHNKIWVIPERDTFTNPEEGDLN
PPPEAKQVPVSYYDSTYLSTDNEKDNYLKGVTKLFERIYSTDLGRMLLTSIVRGIPFWGG
STIDTELKVIDTNCINVIQPDGSYRSEELNLVIIGPSADIIQFECKSFGHDVLNLTRNGY
GSTQYIRFSPDFTFGFEESLEVDTNPLLGAGKFATDPAVTLAHELIHAEHRLYGIAINPN
RVFKVNTNAYYEMSGLEVSFEELRTFGGHDAKFIDSLQENEFRLYYYNKFKDVASTLNKA
KSIIGTTASLQYMKNVFKEKYLLSEDTSGKFSVDKLKFDKLYKMLTEIYTEDNFVNFFKV
INRKTYLNFDKAVFRINIVPDENYTIKDGFNLKGANLSTNFNGQNTEINSRNFTRLKNFT
GLFEFYKLLCVRGIIPFKTKSLDEGYNKALNDLCIKVNNWDLFFSPSEDNFTNDLDKVEE
ITADTNIEAAEENISLDLIQQYYLTFDFDNEPENISIENLSSDIIGQLEPMPNIERFPNG
KKYELDKYTMFHYLRAQEFEHGDSRIILTNSAEEALLKPNVAYTFFSSKYVKKINKAVEA
FMFLNWAEELVYDFTDETNEVTTMDKIADITIIVPYIGPALNIGNMLSKGEFVEAIIFTG
VVAMLEFIPEYALPVFGTFAIVSYIANKVLTVQTINNALSKRNEKWDEVYKYTVTNWLAK
VNTQIDLIREKMKKALENQAEATKAIINYQYNQYTEEEKNNINFNIDDLSSKLNESINSA
MININKFLDQCSVSYLMNSMIPYAVKRLKDFDASVRDVLLKYIYDNRGTLVLQVDRLKDE
VNNTLSADIPFQLSKYVDNKKLLSTFTEYIKNIVNTSILSIVYKKDDLIDLSRYGAKINI
GDRVYYDSIDKNQIKLINLESSTIEVILKNAIVYNSMYENFSTSFWIKIPKYFSKINLNN
EYTIINCIENNSGWKVSLNYGEIIWTLQDNKQNIQRVVFKYSQMVNISDYINRWIFVTIT
NNRLTKSKIYINGRLIDQKPISNLGNIHASNKIMFKLDGCRDPRRYIMIKYFNLFDKELN
EKEIKDLYDSQSNSGILKDFWGNYLQYDKPYYMLNLFDPNKYVDVNNIGIRGYMYLKGPR
GSVVTTNIYLNSTLYEGTKFIIKKYASGNEDNIVRNNDRVYINVVVKNKEYRLATNASQA
GVEKILSALEIPDVGNLSQVVVMKSKDDQGIRNKCKMNLQDNNGNDIGFIGFHLYDNIAK
LVASNWYNRQVGKASRTFGCSWEFIPVDDGWGESSL*
>PROKKA_00007 Autolytic lysozyme
MLKGIDVSEHQGEIGWKAVKNSGIQFAILRAGYGKNNIDKQFINNANGCTSVGMPFGLYW
FSYAYTENMARKEAQYCVAQAKKYKISYPICYDLEYDTIRYANNYGVTITKSLATKMVHA
FCQEVERNGYFAMNYSNQDFLLNKFDSNLLKRYALWYAWYNNSLNRKCGIWQYSENGRVP
GIAGAAVDMNYCYLNMPGAFNTSPNKNTFRGGHYLIRELQQEINSQGLGEVVVDGIAGQA
TINSAPVCKQGARGGITKVIQQMLISIGYPVGSHGADGVFGDSTVTAIKAFQRDCHLVAD
GIVGKETWKALFRNLK*
>PROKKA_00008 hypothetical protein
MRKIKFSKKEQSKELINYIDGDWAEEIMHLVHNKETKKLEIWENRSFGEKYIEITDVFDP
KYNVYFNERDRGRNK*
>PROKKA_00009 hypothetical protein
MYILMREIEVVINDVGLSDFEIELEEDENN*
>PROKKA_00010 Arsenate reductase
MKSKVAFICVHNSCRSQMAEALGKLFASDIFESYSAGTETKPVINQDAVRIIKKLYGVDM
NECHTSKLLDDIPKIDIAIKMGCNVICPFLPAKHIEDWGLEDPTGKSDEEFINTAKIIED
KIKDLANRIKNKQIDLDK*
>PROKKA_00011 C_GCAxxG_C_C family protein
MMNNVDFDKIREVAENYYRNGDFYCSEAVVKTIRDEFKIEVSDDVIAMASGFPVGIGGSG
CTCGAITGGIMALGMVFGRKEAKDPRVAKSMELSKKLHDDFKEEHKSLCCRSLTKGMELG
SKEHMDQCIAFTGEVAERVARIIVENSK*
>PROKKA_00012 Transcriptional repressor SdpR
MSLNYDDNAKIIKALSDGSRLKIIDILSCGEKCACDILEHFGFTQPTLSHHMKVLIDCGL
VKSRKEGLWSYYSLNITNCNKLILFFMNIITDTDDCICKNKSKCDCK*
>PROKKA_00013 Arsenical resistance operon trans-acting repressor ArsD
MKKMIIFDPAMCCSTGVCGPSVDPELLRVATIINRLKNNGILVERHNLTSNPQIFVDNKE
INEILNKEGVEILPVTMVDGIIVKTKAYPTNKEFCKLLDIPEDYLKITIKNPSKGCNCKG
GCC*
>PROKKA_00014 Arsenical pump-driving ATPase
MMFKKFNVEDINLTKYLFFTGKGGVGKTSTACAIAVALADSGKKIMLVSTDPASNLQDVF
NTKLNNKGVYIKEVPNLVVANFEPEEAAAEYRESVIAPYRGKLPEVVLKNMEEQLSGSCT
VEIAAFNEFSTFITDEKVEKEYDHIIFDTAPTGHTLRMLQLPSAWSNFINESTHGASCLG
QLSGLESKREVYKNAVNTLADKDKTTLILVSRPEVSPLKEAERASKELQDIGVNNQVLVI
NGVLEEHEDYLSNAIYTKQQKALEDIPESLKTVETFQIPLRPYNVTGLENVRAFLRNNNI
KYNDEKLNTTNIPKLNEVIEDLYNTDKKVIFTMGKGGVGKTTIAAAIAVGLAKKGKKVHL
TTTDPADHLKFVLDEDYGITLSHIDEKEELEKYKEEVLSKARKTMSEDDIAYVEEDLRSP
CTQEIAVFRAFAEIVERSENEVVVIDTAPTGHTLLLLDSTQSYNKEIQRSQGDIPESVKK
LLPKLRNEENTEVIIVTLAETTPVYEAMRLQEDLNRAGIHSKWWVINSSFYVADTTNSIL
KVKANNEVQWINKVNEISKGNFAVIEWIPKEVKGEILNDLIN*
>PROKKA_00015 Arsenate reductase
MKPKVAFICVHNSCRSQMAEALGRLFASDVFHSYSAGTETKVQINQDAVRIINDMYGVDM
NKEHRSKLITDIPEVDIAIKMGCNVVCPFLPSKHTEDWGLEDPTGKSDEEFIKTAKAIEE
KIKDLSERIKNNKINLM*
>PROKKA_00016 arsenical-resistance protein
MSLKSKEKNKGLGIFERYLTIWVGLCIIIGILIGQFIPQIPEILNKFEYYNVSIPVAILI
WLMIYPMMLKIDFNSIVGVTKKPRGLIVTCVTNWLIKPFTMYLIASFFLKVVFKAFIPGN
LATEYLAGAVLLGAAPCTAMVFVWSYLTKGDPAYTLVQVAVNDLIILIAFAPIVAFLLGV
SDVTVPYGTLILSTILFVVIPLTAGYLTRKSVIKNKGIEYFNDVFLKKFDNVTIIGLLLT
LVIIFSFQGEIILNNPLHILLIAVPLTIQTFLIFCIAYGWAKLWKLPHNIAAPAGMIGAS
NFFELAVAVAISLFGLKSGAALATVVGVLTEVPIMLTLVKIANNTRGWFSTETIEK*
>PROKKA_00017 hypothetical protein
MKWEYKVIEINSIKYLGSPINLQNELNNYGEEGWELIGILKKPHEGVGWTVSPDEGSVIF
KRSLAIG*
